Vinay Prasad Rejoins FDA Amidst Regulatory Turmoil

1 min read
Source: statnews.com
Vinay Prasad Rejoins FDA Amidst Regulatory Turmoil
Photo: statnews.com
TL;DR Summary

Vinay Prasad is returning to the FDA to resume his role overseeing biologics, including vaccines and gene therapy, after a brief departure amid tensions related to a Duchenne muscular dystrophy gene therapy and political criticisms.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 1 min read

Condensed

80%

17335 words

Want the full story? Read the original article

Read on statnews.com